WebWire | News by Industry : Class Actions / Lawsuits http://www.webwire.com/ Class Actions / Lawsuits News by WebWire en Copyright © 2012 WebWire. All Rights Reserved. Sat, 4 Feb 2012 01:26:06 EST WebWire | News by Industry : Class Actions / Lawsuits 140 32 http://www.webwire.com/ http://www.webwire.com/imgs/webwire_logo_140x32.gif Lawsuit: Frito-Lay's Genetically Modified Ingredients Are Not 'All-Natural' http://www.webwire.com/ViewPressRel.asp?aId=152298 Thu, 2 Feb 2012 11:31:39 EST A proposed class-action lawsuit filed in New York alleges that Frito-Lay misled consumers by advertising that their Tostitos and SunChips brands are 'all-natural' when they contain corn and oils from genetically modified plants. The suit seeks to recover damages based on the claim that consumers allegedly choose to pay more for an 'all-natural' product, rather than similar products that were not.
 
The plaintiff, Chris Shake, believes that marketing the products as 'all-natural' is deceptive, because genetically engineered plants have had their genetic material altered artificially in a laboratory—not through natural processes. A similar lawsuit was also filed in California last year.
 
Frito-Lay, owned by PepsiCo Inc., maintains that it has followed all the industry's regulatory requirements.  
 
Genetically modified organisms (GMO) in the food industry have become a controversial topic in recent years, and the U.S. Food and Drug Administration (FDA) has been petitioned to require food labels to indicate clearly the presence of genetically engineered ingredients.
 
'The food industry is encountering new challenges, and EMSL Analytical is constantly assessing and implementing new technologies and methods to serve our clients better,' states Joy DellAringa, M.S., RM (NRM), CFSP, National Food Microbiology Supervisor at EMSL. 'We offer advanced testing services for food adulteration, GMO, and quality control, and our results are legally defensible.'
 
For more information on EMSL's food testing services, please contact EMSL at (800) 220-3675, email info@emsl.com, or visit www.EMSL.com or www.FoodTestingLab.com.
 
About EMSL Analytical, Inc.
EMSL Analytical, Inc. is a full service testing company providing quality lab services under the same private ownership since 1981. Including the corporate lab facility in Cinnaminson, NJ, EMSL Analytical operates over thirty laboratories nationwide in the US and Canada. We provide analytical services for environmental, indoor air quality (IAQ), industrial hygiene, forensics and materials science, consumer products, food safety, PCR, pharmaceutical, asbestos, lead, and radiological samples. The company has an extensive list of accreditations from leading organizations, as well as state and federal regulating bodies. Please see our website for a complete listing of accreditations.
 

— WebWireID152298 —

WebWire® | More Feeds

]]> Agriculture / Aquaculture Big Box Retail / Supermarkets Class Actions / Lawsuits Environment Food / Beverages WebWireID152298 Article Searcy Denney Law Firm Reports $3.5 Million Verdict in Tobacco Litigation http://www.webwire.com/ViewPressRel.asp?aId=152255 Wed, 1 Feb 2012 18:11:45 EST West Palm Beach, FL – Attorney Brian Denney announced that a Highlands County jury awarded Theodore Hallgren $3,500,000.00 against Philip Morris USA Inc. and R.J. Reynolds Tobacco Company for the wrongful death of his wife, Claire Hallgren, who died of lung cancer after nearly 60 years of smoking cigarettes made by those companies. The verdict includes $1,500,000 in punitive damages against the defendants.
 
Brian R. Denney and T. Hardee Bass of Searcy Denney Scarola Barnhart & Shipley, represented Mrs. Hallgren's husband, Theodore Hallgren, now 92.  The attorneys stated that the evidence in the trial showed that Mrs. Hallgren started smoking as a teenager, and was already a regular, daily smoker by the time she was sixteen years old in 1938, nearly 30 years before the first warning labels ever appeared on cigarette packs.  Under the standard required by the Florida Supreme Court's "Engle" decision, the plaintiff needed to prove that Mrs. Hallgren was addicted to nicotine and nicotine addiction caused her death.
 
Mr. and Mrs. Hallgren met at Chicago's Hurst High School in 1938.  They married in 1942, shortly before Mr. Hallgren, a Captain in the United States Army, was deployed to the Europe to fight in World War II.  After the war, the Hallgrens settled in the Chicago area, before moving to Florida in 1975.  They were married for 54 years.
 
'The jury in this case was presented with a lot of evidence of tobacco industry conduct and practices, covering a large span of time,' Denney said.  'The jury's verdict is not only an indication that they understood the addictive power of nicotine and how Mrs. Hallgren fought to overcome that addiction; it is also a recognition that these defendants deserved punishment for their intentional misconduct, which included directly marketing cigarettes to children knowing full well they caused lung cancer and were addictive and lying to generations of Americans regarding the danger and addictiveness of their product for one reason –money.'
 
'Mrs. Hallgren is another tragic example of a tobacco industry success story, someone who started smoking as a child decades before warning labels were placed on cigarette packages, who became addicted to the nicotine in cigarettes, and who was unable to break that addiction before it was too late,' said Denney.
 
'Philip Morris USA Inc. and R.J. Reynolds Tobacco Company are forced to stand equal to people like 92 year old Mr. Hallgren within the four walls of a courtroom, whereas outside of the justice system they are able to wield their influence through their financial means.  When fair-minded people hear the evidence in these cases, the common tobacco industry defense themes are flatly rejected.' Said Attorney Hardee Bass
 
A spokesperson for the Searcy Denney law firm said that this case marks eight straight plaintiff's verdicts in Engle progeny tobacco suits by the lawyers for Searcy Denney Scarola Barnhart & Shipley.

— WebWireID152255 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Financial Markets Media Advisory Tobacco WebWireID152255 Article Rottenstein Law Group Alerted to Pfizer's Motion to Consolidate 59 Zoloft Birth Defects Cases into One Multidistrict Litigation http://www.webwire.com/ViewPressRel.asp?aId=152215 Wed, 1 Feb 2012 09:00:00 EST (New York, NY, February 1, 2012) The Rottenstein Law Group, which represents clients with claims stemming from birth defects caused by the antidepressant Zoloft, has learned that Pfizer, the manufacturer of Zoloft, has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (MDL) to consolidate for pretrial proceedings a group of cases filed against the company in Pennsylvania, New York, Illinois, Mississippi, Missouri and Ohio. The stipulations of the motion and some more information on the cases it seeks to consolidate were published in a January 20, 2012 article on the web site, Law.com.
As the article states, all the cases in the group subject to the motion allege that the children of the mothers who took Zoloft during their pregnancies suffered birth defects as a result of using the antidepressant. Pfizer's motion requests that the MDL consolidation of those cases take place in the Southern District of New York, where Pfizer is headquartered. Since New York has three international airports in its vicinity, Pfizer asserts in its motion, New York would be a convenient location for the cases' plaintiffs, who are located all over the country.
Pfizer named the Northern District of Mississippi, the Southern District of Mississippi, or the Northern District of Ohio as alternative locations for the proposed MDL, stating that those locations would also be suitable for the cases' many plaintiffs.
Almost 50 of the cases that are the subject of Pfizer's MDL motion were removed to the U.S. District Court for the Eastern District of Pennsylvania, according to Law.com. 'Pfizer argued in the motion that in the Pennsylvania cases plaintiffs have created an artificial concentration of cases in Pennsylvania by...fraudulently joining Wolters Kluwer Health, a Pennsylvania corporation, as a defendant, in order to defeat diversity jurisdiction,' the article states.
'The plaintiffs' theory against Wolters Kluwer Health is that it was negligent in the publication of the risks and benefits of using Zoloft during pregnancy in its patient education monographs,' the article continues. 'Pfizer argues that the division that published the monographs, Medi-Span, is headquartered in Indiana and has offices in Missouri, so Pennsylvania has no 'real nexus' to the out-of-state plaintiffs, defendants that the drug company argues are located elsewhere and the underlying allegedly negligent transactions.'
The Rottenstein Law Group's  Zoloft Birth Defects Information Center contains social media features that allow for easy sharing on sites like Facebook and Twitter, which enables visitors to spread the word about the potential dangers associated with Zoloft. The firm encourages visitors to link to its sites from their own blogs and Web sites to spread information about dangerous drugs and defective medical devices.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID152215 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals Supplementary Medicine / Nutrition WebWireID152215 Article Rottenstein Law Group Acknowledges Report Claiming Bone Density Retesting Can Be Delayed http://www.webwire.com/ViewPressRel.asp?aId=152099 Tue, 31 Jan 2012 09:00:00 EST (New York, NY, January 31, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has read with interest a report suggesting that patients with normal bone density can postpone retests.
According to an article that appeared recently in the New York Times, a new study reports that 'one loss and osteoporosis develop so slowly in most women whose bones test normal at age 65 that many can safely wait as long as 15 years before having a second bone density test.'
The study, which was published in the New England Journal of Medicine, is 'part of a broad rethinking of how to diagnose and treat the potentially debilitating bone disease that can lead to broken hips and collapsing spines' as reported by Times health writer Gina Kolata. 'A class of drugs, bisphosphonates, which includes Fosamax, has been found to prevent fractures in people with osteoporosis. But medical experts no longer recommend the medicines to prevent osteoporosis itself.'
Despite being the most popular osteoporosis treatment on the market, it has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition that causes the jawbone to literally die because of a lack of blood supply. More recently, there has been a link between Fosamax and low-impact femur fractures experienced from standing height or less. Evidence is mounting that Fosamax and similar drugs prescribed to treat osteoporosis cause a dramatic increase in the risk of this kind of rare fracture to the thigh bone.
As of June 30, 2011, according to Merck, the manufacturer of Fosamax, approximately 1,650 cases, which consist of approximately 2,050 plaintiff groups, had been filed and were pending against the company in both state and federal courts.
The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations.  Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.
[b]About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID152099 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals Supplementary Medicine / Nutrition WebWireID152099 Article Medical Negligence Solicitors Support Peers' Legal Aid Warnings http://www.webwire.com/ViewPressRel.asp?aId=152177 Tue, 31 Jan 2012 04:12:34 EST Oxford-based medical negligence specialist, Darbys Solicitors, is backing peers from the House of Lords, who spoke out earlier this month against the removal of the provision of Legal Aid for claimants in medical negligence cases.
 
Speaking to the House of Lords, the Conservative's Baroness Eaton argued that: 'A civilised society should provide a safety net for the most vulnerable."
 
Liberal Democrat Lord Thomas of Gresford also spoke out in support of retaining Legal Aid provision for medical negligence cases, suggesting that instead of outright abolition, the severity of the injury should dictate whether or not Legal Aid is awarded.
 
He said: "If it is a case which so often happens that people's lives are altered for good, and members of their family's lives are altered for good, surely a humane society should provide legal aid to cover the cost of litigation in those circumstances."
 
In response to the remarks made in the house of lords, clinical negligence expert and lawyer at Darbys Solicitors LLP Richard Money-Kyrle said: 'I absolutely agree with the views expressed in support of retaining Legal Aid provision for medical negligence claimants.
 
'By removing such provision we're straying dangerously close to denying representation and compensation to the poorest in our society, particularly considering the fact that this comes hand-in-hand with the dismantling of the 'no win, no fee' system.'
 
Commenting on the 'no win, no fee' proposals, Mr Money-Kyrle continued: 'Under new government proposals claimants will have to pay up to 25% of their legal fees from their compensation, as opposed to the person at fault having to pay.'
 
Speaking to the Huffington Post, chief executive of the Law Society Desmond Hudson also commented on the wider 'no win, no fee' issue, saying: 'the Government is proposing to further reduce legal aid spending while effectively dismantling the 'no win, no fee' system, which will leave many people without effective access to justice."
 
Advocate General Lord Wallace of Tankerness, speaking to the Lords in support of the removal of Legal Aid provision for medical negligence claims, assured ministers that he would reflect seriously on their concerns.
 
Oxford-based Darbys Solicitors LLP specialises in clinical negligence claims. For more information, visit the company's dedicated medical negligence website at: http://www.darbysmedicalnegligence.co.uk

— WebWireID152177 —

WebWire® | More Feeds

]]> Business Announcements Class Actions / Lawsuits Government Legal Issues Politics WebWireID152177 Article Plaintiffs Win Again in Engle Progeny Tobacco Cases http://www.webwire.com/ViewPressRel.asp?aId=152156 Mon, 30 Jan 2012 17:32:46 EST On January 26, 2012, an Escambia County jury awarded Erskin Donal Ward $2.7 million against R.J. Reynolds Tobacco Company and Liggett Group, LLC, in case number 2008-CA-2135, filed in the First Judicial Circuit, in Escambia County, Florida.
 
The lawsuit filed in the case alleged that Erskin Ward's wife, Mattie Emma Ward, died of emphysema after nearly 50 years of smoking cigarettes made by R.J. Reynolds Tobacco Company and Liggett Group, LLC Philip Morris USA, Inc.
 
Erskin Ward's attorney, James Gustafson said that the jury verdict included $1.7 million in punitive damages against R.J. Reynolds Tobacco Company.
 
James W. Gustafson, Jr. of Searcy Denney Scarola Barnhart & Shipley in Tallahassee, Florida, along with Matt Schultz of the Levin Papantonio Thomas Mitchell Echsner & Proctor firm in Pensacola, Florida represented Mrs. Ward's husband, Erskin Donal Ward, now 76.
 
Mr. Gustafson stated that evidence in the trial demonstrated Mrs. Ward started smoking as a thirteen year old in rural Alabama in 1949, almost 20 years before the first warning labels ever appeared on cigarette packs.  Under the standard required by the Florida Supreme Court's "Engle" decision, the plaintiff needed to prove that Mrs. Ward was addicted to nicotine and nicotine addiction caused her death.
 
"The jury's work and patience in this trial showed," Gustafson said. "The verdict is not only a tribute to a woman who was a treasure to Pensacola and the special education community, but to the hard work the jury did to understand how much things have changed in the past 50 years--and the need to punish R.J. Reynolds for its intentional outrages, what they did to a generation of Americans, including hawking cigarettes to children.'
 
"Mrs. Ward is another tragic example of the best among us, someone who started smoking as a child decades before the warnings, and was killed by addiction to nicotine," said Gustafson.
 
Sources at the Searcy Denney law firm said that this verdict marks eight successive plaintiff's verdicts in Engle progeny tobacco suits by the lawyers for Searcy Denney Scarola Barnhart & Shipley.  "The industry keeps saying they're changing the legal landscape, that they have such powerful defenses to these cases.  When good people see the truth, those defenses are the same glass houses of deceit they always were." said James Gustafson.

— WebWireID152156 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Financial Markets Personal Services Tobacco WebWireID152156 Article Whistleblowers Expose FDA's Illegal Surveillance of Employees - http://www.webwire.com/ViewPressRel.asp?aId=152126 Mon, 30 Jan 2012 10:40:18 EST Washington, DC. January 30, 2012. As reported in today's Washington Post, six current and former employees of the Food and Drug Administration (FDA) have filed a complaint against the FDA in U.S. District Court. The employees are seeking an injunction to stop the agency from illegally spying on employees' private communications to Congress and other oversight agencies.

Linked here are key documents related to this lawsuit and the FDA's spying program.

The complaint details how the FDA targeted its employees with a covert spying campaign that lasted for two years. The FDA began the program after learning that the employees wrote a letter to President-Elect Obama and his transition team in early 2009 detailing government misconduct in approving unsafe medical devices.  The Agency installed (or activated) spyware on their workplace computers and used other technology that to monitor their password-protected Gmail-to-Gmail communications.

In addition to reading the whistleblowers' emails, the FDA took contemporaneous screen shots of the employees' computer screens. Managers used the collected information to learn the identities of confidential whistleblowers and to obtain the details of the public health and safety concerns the whistleblowers intended to disclose to the Office of Special Counsel, Congress and the Agency's own Inspector General.

The FDA also intercepted email communications to and from staff members of the House Committee on Energy and Commerce and the Ranking Member of the Senate Finance Committee.  These Congressional intercepts are linked here.

The FDA's prolonged covert monitoring of the whistleblowers continued even after the HHS Office of Inspector General denied the FDA's request to take any criminal and/or administrative action against the whistleblowers. In their letter of refusal, the OIG explicitly informed the FDA that the whistleblowers' communications to Congress were protected under law.

The managers who spearheaded the surveillance efforts were the same managers involved with the wrongdoing and corruption that the whistleblowers were seeking to report. Lawyers at the FDA and HHS Offices of General Counsel, who should have understood that the program breached the employees' confidentiality, helped FDA managers with their obstruction and retaliation.

In their lawsuit, six FDA whistleblowers who were fired by the agency (including two highly respected medical doctors, a Branch Chief, a former Health and Safety Officer employed by the Public Health Service and a 23-year FDA career M.D./Ph.D Scientist) are requesting a nationwide injunction prohibiting the federal government from targeting whistleblowers with selected surveillance and monitoring.

The lawsuit alleges that such targeted monitoring of whistleblowers violates their First Amendment rights of freedom of speech and association.

Stephen M. Kohn, NWC Executive Director and attorney for six FDA whistleblowers, issued the following statement:

The FDA declared war on employees who were trying to warn Americans about threats to public health and safety.The federal government cannot---and should not---spy on whistleblowers. The First Amendment prohibits targeting whistleblowers and selectively monitoring them using highly intrusive electronic surveillance without a warrant.

Targeting the employees who raise health and safety concerns---or who try to report waste, fraud and abuse to the proper authorities---will have a massive chilling effect on employees.

The FDA's illegal spying program is not just a problem for the six victims in this case. The day we allow the government to spy on employees based on their lawful whistleblower activities is the day we give up privacy for every honest public servant in America.

If permitted to stand, the FDA's whistleblower surveillance program will be used by government agencies throughout the United States to silence employees who want to report misconduct.  Those who are not silenced will be subjected to years of intrusive covert spying designed to dredge up embarrassing information that the agencies can use to destroy the whistleblowers' reputations and careers.

Today, the NWC issued an Action Alert seeking public support for the FDA whistleblowers and demanding an end to the federal government's targeted and selective surveillance of whistleblowers.
The NWC obtained the intercepted emails as a result of a lawsuit filed under the Freedom of Information Act and from documents produced by the FDA as a result of administrative actions taken against three of the whistleblowers.

Links:  FDA Whistleblower Complaint
Intercepted Emails from FDA Whistleblowers
Letter from the HHS OIG
Support FDA Whistleblowers
PageNWC Action Alert

***

— WebWireID152126 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Government Legal Issues Medical / Pharmaceuticals Politics WebWireID152126 Article Rottenstein Law Group Distressed by Further Manufacturing Gaffes of DePuy, as Detailed in FDA Warning Letter http://www.webwire.com/ViewPressRel.asp?aId=152098 Mon, 30 Jan 2012 09:00:00 EST (New York, NY, January 30, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, has reviewed with concern, but not surprise, a recent letter sent by the U.S. Food and Drug Administration (FDA) to the embattled company.
The FDA has released a warning letter recently sent to DePuy Orthopaedics, a division of Johnson & Johnson, in which the agency identified fourteen devices and related components being manufactured at the company's Warsaw Indiana location as 'adulterated' under applicable regulations because DePuy does not have approved applications for premarket approval (PMA) in effect, or approved applications for investigational device exemptions (IDE). In other words, the enumerated devices have no premarket clearance or approval, or have been modified in ways that could impact their safety and effectiveness, therefore requiring separate evaluations before they may be sold.
'Your firm should take prompt action to correct the violations addressed in this letter,' the FDA warns. 'Failure to promptly correct these violations may result in regulatory action being initiated by the FDA without further notice. These actions include, but are not limited to, seizure, injunction, and/or civil money penalties. Also, federal agencies may be advised of the issuance of Warning Letters about devices so that they may take this information into account when considering the awarding of contracts.'
The FDA letter can be viewed here.
In August 2010, DePuy announced a global recall of its ASR Hip Resurfacing System and ASR XL Acetabular System. 93,000 patients worldwide had an ASR device implanted before the recall, according to published data provided by DePuy. The company recalled its ASR devices after the National Joint Registry of England and Wales made public data showing that, within five years, about 12 percent of recipients of the hip resurfacing system and about 13 percent of recipients of the acetabular system needed amended surgery, as was reported by the Times.
Rochelle Rottenstein, principal of the Rottenstein Law Group, says, 'We implore anyone with a friend or relative who has received a hip replacement device since 2003 to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer.'
The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations.  Affected individuals can also stay apprised of the latest developments in the DePuy situation by visiting the DePuy  ASR Hip Replacement Lawsuit Information Center. The site is equipped with easy-to-use social media features which will enable users to spread the word about DePuy ASR hip replacement device failures.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID152098 —

WebWire® | More Feeds

]]> Biotechnology Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals WebWireID152098 Article Come and see the team from Sorrymate.com at this week's Motorcycle News show in London, and grab your free SMIDSY card http://www.webwire.com/ViewPressRel.asp?aId=152058 Fri, 27 Jan 2012 11:38:59 EST The keen bikers from motorcycle accident claims specialist Sorrymate.com are hitting the road again this week, taking a stand at the big Motorcycle News show at London's ExCeL arena.

"The greatest bike show on earth" will feature the hottest new bikes of 2012, and promises massive savings on all sorts of bike kit and accessories.

But one of the hottest tickets in town will be the dinky SMIDSY cards which the Sorrymate.com people will be handing out, explaining how bikers can take advantage of free legal expenses cover in the event of them having to make an insurance claim for an accident which wasn't their fault.

All keen bikers themselves, the people from Sorrymate.com make up a team of specialist solicitors who every year advise many motorcyclists who have been involved in a non-fault accident.

Paul Dutton from Sorrymate.com explained that the firm has a stand at all the major bike shows across the UK, and over the past year has handed out thousands of SMIDSY – an acronym for "Sorry mate, I didn't see you" – cards detailing the services he and his colleagues offer.

This includes understanding and professional handling of all motorbike accident compensation claims, when a rider has been involved in an accident which isn't their fault.

"We love the excitement of the big shows such as Motorcycle News Live, but we also realise that, away from all the high-revving action, when bikers are out on the road, they encounter risks on the road, day in, day out," said Paul.

"We want them to know that, if they ever need to make a motorcycle accident claim, we offer them free advice to make the process as smooth and hassle-free as possible.

"As bikers ourselves, we get just as much excitement from being at these shows as they do," he added. "But on their way home, or just while they're riding around, they could be the victim of an accident which isn't their fault.

"Besides the physical injuries they might have to deal with, we want to show them that they don't have to worry about getting advice and recompense for the damage to their bikes and any loss of income that might result.

"All they need to do is enlist our help, and we'll make sure they know what help they're entitled to – including the right to appoint a solicitor of their choice to handle their case."
Sorrymate.com's 'smidsy' card holders know that, if they need to make a claim, their case won't be sold on to just any other company, but will be handled by experts.
So grab a bit of this little peace of mind by visiting the Sorrymate.com team on stand N320 at the Motorcycle Live show, taking place from 10am to 5pm on Thursday and Friday, February 2 and 3, and between 9am and 6pm on Saturday and Sunday, February 4 and 5.
 
About sorrymate.com:
Sorrymate.com deals with all manner of motorcycle accident claims, road traffic accident claims and smidsy claims. If a motorbike accident wasn't your fault, the company will try to ensure you receive 100 per cent compensation without paying a penny. The people behind the company are bikers too, so they understand such situations.
 
 
For further information contact Paul Dutton:
Email: marketing@sorrymate.com            Website: http://www.sorrymate.com/
Phone: 0800 6 300 301

— WebWireID152058 —

WebWire® | More Feeds

]]> Automotive Class Actions / Lawsuits Legal Issues WebWireID152058 Article Attorney Now Giving Away LLC Operating Agreements http://www.webwire.com/ViewPressRel.asp?aId=152004 Wed, 25 Jan 2012 19:18:02 EST OREM, Utah January 25, 2012 - Lee R. Phillips, a nationally known speaker, author and attorney, who specializes in asset protection and estate planning, announced today that he will be giving away one of the most important pieces to an LLC - The LLC Operating Agreement.

Most business owners don't realize how important the LLC Operating Agreement is when forming an LLC.  Lee is an attorney and counselor to the US Supreme Court who has 'seen it all' and knows how quickly the corporate veil can be pierced if an LLC is not structured properly and guidelines not met.  He says that most LLCs are set up through legal professionals which is good, however, in most cases, no time is spent with the business owners in teaching them how to customize the LLC Operating Agreement for their business.

Without a customized operating agreement, the LLC is worthless and the business has no protection.  'It's sad that more business owners don't realize this until it's too late,' Lee says.   'That's why I've decided to do something about it.'  The best way to protect yourself and your business is to understand the rules and the guidelines you have to follow to maintain the LLC.  It all starts with the LLC Operating Agreement. 

Lee Phillips has spent his career educating individuals and business owners about the proper way to protect one's assets.  He has written a book called Guaranteed Millionaire which focuses on and teaches how to use the law to protect one's assets.  To learn more about the guidelines to forming an LLC or to get your own LLC operating agreement template to either use for your LLC or compare against the one you have visit http://www.llcwizard.com.

— WebWireID152004 —

WebWire® | More Feeds

]]> Business Announcements Class Actions / Lawsuits Legal Issues WebWireID152004 Article Rottenstein Law Group Hoping European Breast Implant Recall Convinces U.S. Regulators to Rethink Proposal to Accelerate FDA's Medical Device Approval Process http://www.webwire.com/ViewPressRel.asp?aId=151840 Tue, 24 Jan 2012 09:00:00 EST (New York, NY, January 24, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the adverse effects of vaginal mesh, is in agreement with a January 19 Bloomberg article stating that the scandal over leaking French breast implants should convince U.S. regulators that American consumers would not benefit from speeding up the FDA's medical device approval process.

For the past year, proponents of the European Union's medical device approval process - which allows complex devices to reach consumers in European markets an average of two years sooner than in the U.S. - have been calling for the FDA to adopt a similar process, according to the article. Medical device industry supporters argue that the EU is luring device manufacturers away from the U.S., and contributing to high unemployment rates.

The breast implant debacle in Europe, which involves the removal of thousands of potentially faulty implants manufactured by the now-defunct French company Poly Implants Protheses SA, has brought negative attention to the EU's medical device approval process, however. The European breast implant problem therefore should make U.S. regulators realize that it would be unwise to adopt a medical device approval process similar to the one in Europe, according to Carl Heneghan, an Oxford University teacher who has studied device recalls and is quoted in the Bloomberg article.

'All industry guys in the U.S. say, 'we should have access to these products much sooner, like in Europe,'' the Bloomberg article quotes Heneghan as saying. 'The flip side is, the European people are being used as guinea pigs.'

The importance of subjecting medical devices to comprehensive FDA reviews before they are approved for sale has been highlighted in recent months by the thousands of women in the U.S. who have suffered injuries as a result of vaginal mesh implants. The implants were granted FDA approval based on their similarity to devices already on the market, without the benefit of human testing. The implants have so far spawned more than 650 lawsuits filed by patients alleging that they have been significantly injured as a result of having surgical mesh products implanted transvaginally.

Anyone seeking more information about vaginal mesh can visit the Rottenstein Law Group's Vaginal Mesh Lawsuit Information Center. The site has vital information about the dangers of this medical device, along with easy-to-use social media features that allow for easy sharing on sites like Facebook and Twitter. Visitors are also encouraged to link to their own Web sites and blogs in order to spread the word about defective medical products and dangerous drugs.

About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID151840 —

WebWire® | More Feeds

]]> Biotechnology Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals WebWireID151840 Article Jim Couri and Scams Inc are in agreement to enter into joint ventures to pursue the corrupt, scammers and swindlers http://www.webwire.com/ViewPressRel.asp?aId=151892 Tue, 24 Jan 2012 03:00:00 EST BRIGHTON, Colorado (January 24, 2012) - Scams Inc, a Colorado-based news organization which reports on a variety of scams, swindles and corrupt activities, is pleased to announce an agreement with Jim Couri to provide commentary and insight to Scams Inc via videos posted to ScamsInc.com.

Jim Couri, a Founder, resigned from Scamraiders in 2009 to begin a long and ongoing arduous fight against Stage 4 cancer and other grave medical disorders. Scams Inc in early 2011 closed on the purchase of Scamraiders business, domains, trademarks and copyrights.

Jim continues his cancer fight and active treatments as well as his being confronted with a myriad of medical complications, heart disease, intestinal disorders and multiple surgeries. Jim cannot travel. Jim is range-bound from Southern California where he resides with his wife and UCLA Medical Center where most of his treatment, surgeries and medical care occurs.  

That said, Scams Inc has encouraged Jim to devote some time to aiding in the Scams Inc fight and exposes of corruption; particularly in the areas of corrupt lawyers, corrupt courts and judges and other white collar crimes, bribery, collusion and sell out lawyers, fraud and more.

Jim Couri has consented to become a Consultant to Scams Inc and has consented to produce Videos that will be aired on Scams Inc, Scamraiders and on YouTube that will reveal, expose and denude the corruption on going in courts and elsewhere.

Scams Inc's Investigators will be working with Jim to follow-up Jim's leads of corrupt and crooked lawyers, judges, court referees, bribery at the courthouses, sell-outs by cheating lawyers, etc.

All of Jim's videos will contain explosive and detailed material, naming names and all exposes will have been investigated and verified by interviews, court and other documents, pleadings and recordings, etc.

Jim Couri will continue in these capacities as long as they do not impact his medical care and treatment.

All videos (Jim's and others), will be created, produced and launched from Scams Inc/Scamraiders facilities in Southern California and from Jim's home.

All Scams Inc can further report at this moment is:

'We welcome Jim Couri and his courage, wisdom, help and guidance -- and we warn corrupt, sleazy, railroading lawyers and back-room colluding, 'sell-out' judges, look out -our investigators will open the can of worms and Scams Inc will expose you.'

— WebWireID151892 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Government Legal Issues Multimedia / Online / Internet Publishing / Information Services WebWireID151892 Article Drug Ring Indicted for Trafficking Methamphetamine from Mexico into Arkansas http://www.webwire.com/ViewPressRel.asp?aId=151881 Mon, 23 Jan 2012 15:19:12 EST Federal and state officials arrested 22 people on 36 counts of trafficking an atypical form of methamphetamine smuggled from Mexico into Arkansas. Authorities also seized 13.3 pounds of the drug, seven vehicles, $163,590, and five guns from the criminal organization.
 
The type of methamphetamine seized in this operation is not the common kind made in small batches using ephedrine, according to Reuters. This crystal form of the drug is called 'ice' and usually produced in Mexico. Arkansas has become a regional distribution hub for Mexican ice methamphetamine.
 
Methamphetamine is a highly addictive and potentially lethal stimulant that can be taken orally, snorted, smoked, and injected. The Drug Enforcement Administration reports that high doses have been associated with aggressive and violent behavior—in addition to irritability, tremors, convulsions, anxiety, paranoia, neurotoxic effects, hyperthermia, and cardiovascular collapse. Numerous ways to manufacture the drug exist, including small scale production. The toxic waste resulting from methamphetamine production poses a serious health risk not only to the individuals making the drug, but to those in the vicinity of the lab as well.
 
'Methamphetamine production and use has become a widespread problem in the United States,' states Scott Van Etten, CIH, EMSL Analytical's National Director of Industrial Hygiene. 'EMSL has received increasing requests to test for methamphetamine as its frightening popularity continues to grow.'

For more information on EMSL's testing services, please contact EMSL at (800) 220-3675, visit www.EMSL.com or email info@EMSL.com.

About EMSL Analytical, Inc.
EMSL Analytical, Inc. is a full service testing company providing quality lab services under the same private ownership since 1981. Including the corporate lab facility in Cinnaminson, NJ, EMSL Analytical operates over thirty laboratories nationwide in the US and Canada. We provide analytical services for environmental, indoor air quality (IAQ), industrial hygiene, forensics and materials science, consumer products, food safety, PCR, pharmaceutical, asbestos, lead, and radiological samples. The company has an extensive list of accreditations from leading organizations, as well as state and federal regulating bodies. Please see our website for a complete listing of accreditations.

— WebWireID151881 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Health Care / Hospitals Medical / Pharmaceuticals WebWireID151881 Article Rottenstein Law Group Acknowledges Scheduling of Examinations of DePuy Executives as Part of Pending Litigation http://www.webwire.com/ViewPressRel.asp?aId=151839 Mon, 23 Jan 2012 09:00:00 EST (New York, NY, January 23, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the recall of defective hip replacement devices manufactured and sold by DePuy Orthopaedics, acknowledges with support the scheduling of examinations of DePuy executives.
With the discovery phase underway in the multidistrict litigation surrounding DePuy Orthopaedics's embattled ASR hip replacement system, the plaintiff's liaison counsel has called for examinations of DePuy executives, to be held in February and March. The discovery phase of litigation involves a comprehensive trading of information relevant to the claims and defenses raised in a lawsuit.
By notices dated January 12, 2012, and filed with the United States District Court for the Northern District of Ohio, Western Division – where In re: DePuy Orthopaedics Inc. ASR Hip Implant Product Liability Litigation (case no 1:10-md-2197) is pending before the Honorable David A. Katz – the plaintiffs' lawyers have scheduled the video depositions of Sally Hunter and Pam Plouhar. Ms. Hunter is the Vice President of Worldwide Regulatory Affairs for DePuy, a division of Johnson & Johnson; Ms. Plouhar is DePuy's Vice President of Worldwide Clinical Affairs. Ms. Hunter is scheduled to be examined in England in early February; Ms. Plouhar in Indiana in early March.
In an article that appeared on the New York Times Web site in March 2010, Ms. Hunter was quoted as saying that '[w]ith declining sales of this particular product in its market segment, we are focusing on newer technologies.' Yet, in August 2010, DePuy announced a global recall of its ASR Hip Resurfacing System and ASR XL Acetabular System. 93,000 patients worldwide had an ASR device implanted before the recall, according to published data provided by DePuy. The company recalled its ASR devices after the National Joint Registry of England and Wales made public data showing that, within five years, about 12 percent of recipients of the hip resurfacing system and about 13 percent of recipients of the acetabular system needed amended surgery, as was reported by the Times.
Rochelle Rottenstein, principal of the Rottenstein Law Group, says, 'We implore anyone with a friend or relative who has received a hip replacement device since 2003 to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer.'
The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations.  Affected individuals can also stay apprised of the latest developments in the DePuy situation by visiting the DePuy  ASR Hip Replacement Lawsuit Information Center. The site is equipped with easy-to-use social media features which will enable users to spread the word about DePuy ASR hip replacement device failures.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID151839 —

WebWire® | More Feeds

]]> Biotechnology Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals WebWireID151839 Article Lead Harms Children at Lower Levels than Previously Thought, Study Finds http://www.webwire.com/ViewPressRel.asp?aId=151821 Fri, 20 Jan 2012 16:49:16 EST Experts say that the threshold for diagnosing lead poisoning in children should be lowered in light of new evidence that lead can harm children at lower levels than previously thought. Consequently, the Centers for Disease Control and Prevention (CDC) may revise its standards in response to a federal advisory committee's recommendation.
 
According the New York Times, this is the first recommendation of its kind in twenty years and would translate into hundreds of thousands more children meeting the standard for lead poisoning.
 
Children are at the greatest risk for lead poisoning, because they are still developing and their small bodies would contain higher concentrations than adults. Possible complications resulting from lead poisoning are learning disabilities, mental retardation, behavioral problems, lowered intelligence, stunted growth, and hearing impairment.
 
'As the first step in the lead removal process, EMSL Analytical analyzes soil, drinking and waste water, air, wipes, and paint chip samples for competitive prices,' states Shannon Kauffman, Supervisor of EMSL's Metals Laboratory. 'Furthermore, we offer legally defensible lead testing at locations across the country.'
 
For more information on EMSL's testing services, please contact EMSL at (800) 220-3675, visit www.EMSL.com, or email info@EMSL.com.

About EMSL Analytical, Inc.
EMSL Analytical, Inc. is a full service testing company providing quality lab services under the same private ownership since 1981. Including the corporate lab facility in Cinnaminson, NJ, EMSL Analytical operates over thirty laboratories nationwide in the US and Canada. We provide analytical services for environmental, indoor air quality (IAQ), industrial hygiene, forensics and materials science, consumer products, food safety, PCR, pharmaceutical, asbestos, lead, and radiological samples. The company has an extensive list of accreditations from leading organizations, as well as state and federal regulating bodies. Please see our website for a complete listing of accreditations.

— WebWireID151821 —

WebWire® | More Feeds

]]> Architecture / Construction / Building Class Actions / Lawsuits Health Care / Hospitals Real Estate Youth / Children WebWireID151821 Article EMSL Toronto Testing Laboratory Receives A2LA Accreditation http://www.webwire.com/ViewPressRel.asp?aId=151807 Fri, 20 Jan 2012 10:21:07 EST EMSL Analytical, a leading provider of advanced environmental laboratory services, announced today that their Toronto, Ontario laboratory has been accredited by the American Association for Laboratory Accreditation (A2LA) for mold and lead testing.  The news has already spread quickly with indoor air quality and environmental professionals who previously had limited choices for accredited laboratory facilities.
 
Molds live in soil, on plants and on dead or decaying matter.  They produce tiny spores to reproduce, just as some plants produce seeds. These mold spores can be found in both indoor and outdoor air, and settled on indoor and outdoor surfaces. When mold spores land on a damp spot, they may begin growing and digesting whatever they are growing on in order to survive.  Since molds gradually destroy the things they grow on, you can prevent damage to building materials and furnishings and save money by eliminating mold growth.
 
Lead has long been recognized as a harmful environmental pollutant. In late 1991, the Secretary of the United States Department of Health and Human Services called lead the "number one environmental threat to the health of children in the United States." There are many ways in which humans are exposed to lead: through air, drinking water, food, contaminated soil, deteriorating paint, and dust. Airborne lead enters the body when an individual breathes or swallows lead particles or dust once it has settled. Before it was known how harmful lead could be, it was used in paint, gasoline, water pipes, and many other products.
 
'EMSL is pleased to be receiving this recognition from A2LA,' reported Joseph Frasca, Senior Vice President, Marketing at EMSL Analytical.   'Canadian air quality professionals have come to rely on EMSL's Canada laboratory for access to the high quality mold, asbestos and lead testing,' Frasca went on to report.
 
 
For more information on EMSL's testing services, please contact EMSL at (800) 220-3675, visit www.EMSL.com, or email info@EMSL.com.
 
 About EMSL Analytical, Inc.
EMSL Analytical, Inc. is one of the nation's leading testing laboratories with over 39 locations throughout the United States and Canada. EMSL is a nationally recognized and locally focused provider specializing in consumer product, environmental, industrial hygiene, indoor air quality, microbiology, radon, food and materials testing services to professionals and the general public. EMSL maintains an extensive list of accreditations from leading organizations as well as state and federal regulating bodies including, but not limited to A2LA, AIHA EMLAP, AIHA IHLAP, AIHA ELLAP, NVLAP, CDC Elite, CPSC, CA ELAP, NY ELAP, TX DOH, NJDEP and multiple other state accrediting agencies. In addition, EMSL carries a wide range of sampling products, IAQ investigative equipment, thermal imaging cameras, and more. Please visit the website at www.EMSL.com for a complete listing of lab accreditations, products catalog, sampling guides, and training events.

— WebWireID151807 —

WebWire® | More Feeds

]]> Architecture / Construction / Building Class Actions / Lawsuits Commercial Services Health Care / Hospitals Youth / Children WebWireID151807 Article Rottenstein Law Group Made Aware of New Study Possibly Linking Zoloft with Persistent Pulmonary Hypertension in Newborns http://www.webwire.com/ViewPressRel.asp?aId=151607 Wed, 18 Jan 2012 09:00:00 EST (New York, NY, January 18, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the birth defects caused by the antidepressant Zoloft, has learned of a new study possibly linking pregnant women who take selective serotonin reuptake inhibitors (SSRIs) which include Zoloft, and infants born with persistent pulmonary hypertension (PPHN).
According to a Yahoo! News article that appeared on January 12, a new Swedish study shows that pregnant women who take an antidepressant like Zoloft late in their pregnancies are twice as likely to give birth to a child with PPHN, a condition that could lead to shortness of breath and difficulty breathing.
The study, conducted at the Centre for Pharmacoepidemiology at Karolinska University Hospital in Stockholm, looked at data from more than 1 million births from 1996 to 2007 in Denmark, Finland, Iceland, Norway and Sweden, according to the article.
'Of the nearly 11,000 mothers who used an SSRI in late pregnancy, 33 babies (0.2 percent) were born with persistent pulmonary hypertension,' the article states. 'Among the 54,000 mothers who had previously been diagnosed with a mental problem but who did not SSRIs during their pregnancy, 114 infants were born with persistent pulmonary hypertension.'
The Rottenstein Law Group's  Zoloft Birth Defects Information Center contains social media features that allow for easy sharing on sites like Facebook and Twitter, which enables visitors to spread the word about the potential dangers associated with Zoloft. The firm encourages visitors to link to its sites from their own blogs and Web sites to spread information about dangerous drugs and defective medical devices.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID151607 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals Supplementary Medicine / Nutrition WebWireID151607 Article The Law Offices of Howard J. Weintraub is Georgia's go to DUI Defense Attorney http://www.webwire.com/ViewPressRel.asp?aId=151659 Tue, 17 Jan 2012 14:10:37 EST Criminal defense attorneys are an integral part of the criminal justice system, defending the legal rights of the individuals charged with a crime. Depending on the nature of the charge a defendant faces, a federal defense attorney is needed to defend against a federal criminal charge in a federal district court, or for individuals facing a DUI charge, a DUI defense attorney may be retained to represent the defendant to seek a just outcome.

In the state of Georgia, driving under the influence, or DUI, is considered a crime, and if convicted, the person can face severe penalties. Like with any criminal defense systems, the Georgia criminal defense allows individuals charged with DUI to hire a DUI defense attorney to contest in court against their DUI charges. Depending on the circumstances and the attorney performance, conviction results can be very different.

The Law Offices of Howard J. Weintraub has decades of combined attorney experience dealing with criminal drunk driving cases. Only the best DUI attorneys can help defendants obtain a minimal sentence and fines, or potentially have a DUI charge dismissed. Without aggressive court defending by the best DUI attorneys, a DUI charge can go uncontested in court and individuals facing the charge are not fully exercising their entitled legal rights.

DUI attorneys from The Law Offices of Howard J. Weintraub all have an intimate understanding of the relevant law and recognize what's on the line for the individuals facing the charges and will fight for the most desirable outcomes.

— WebWireID151659 —

WebWire® | More Feeds

]]> Class Actions / Lawsuits Legal Issues Not for profit WebWireID151659 Article Rottenstein Law Group Applauds Report of Lubricant Discovery that Could Potentially Improve Design of Future Metal Hip Replacement Implants http://www.webwire.com/ViewPressRel.asp?aId=151606 Tue, 17 Jan 2012 09:00:00 EST (New York, NY, January 17, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, is encouraged by a report that researchers might have found a way to make all-metal hips less dangerous to recipients.
According to an article recently published by Reuters, 'a substance that forms in patients with all-metal artificial hips turns out to contain the common lubricant graphite, a discovery that could help in designing longer lasting implants, researchers said.'
All-metal hip implants were designed to be more durable than traditional hip replacement devices which typically are comprised of metal and polyethylene, in order to permit a greater range of motion. Unfortunately, as evidenced by a study sponsored by the U.S. Food and Drug Administration (FDA), patients who receive all-metal hips are more likely to need a 'revision' surgery than those who receive traditional hip implants. In 2010, DePuy Orthopaedics, a division of Johnson and Johnson, recalled an entire line of metal-on-metal hip replacement devices, which were failing at a higher-than-expected rate.
A new study, funded by the National Institutes of Health, conducted by U.S. and German scientists, and published in the journal Science, suggests that 'graphitic carbon in a lubricating layer that forms on the surfaces of the ball and socket in implanted metallic hips [results from] friction when the two surfaces slide together. Previous research had identified the existence of the layer; but it was assumed to be made of proteins,' according to the Reuters article. '[The] findings could help scientists design future metal hips that are less vulnerable to wear and corrosion. For example, device makers could try to enhance the formation of the graphite or develop a way to make it adhere better to the metal.'
'Metal-on-metal hips were designed to wear longer and can accommodate larger femoral heads, which lowers the risk of hip dislocation,' the Reuters article notes. 'But they produce debris in the body that can release metal ions into the blood stream.
More than 450,000 Americans, most with severe arthritis that limits their ability to walk, undergo hip replacement each year. The devices, made of combinations of metals, polymers and ceramics, typically last more than a decade, but their failure rates rise beyond 10 years. Manufacturers include Zimmer Holdings Inc, Wright Medical Group Inc, Smith & Nephew Plc and DePuy.'
The Rottenstein Law Group is advising anyone with a friend or relative who has undergone a hip replacement procedure to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations.  Affected individuals can also stay apprised of the latest developments in the DePuy situation by visiting the DePuy  ASR Hip Replacement Lawsuit Information Center. The site is equipped with easy-to-use social media features which will enable users to spread the word about DePuy ASR hip replacement device failures.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID151606 —

WebWire® | More Feeds

]]> Biotechnology Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals WebWireID151606 Article Rottenstein Law Group Supports FDA Letters Ordering Vaginal Mesh Manufacturers to Study Safety and http://www.webwire.com/ViewPressRel.asp?aId=151605 Tue, 17 Jan 2012 09:00:00 EST New York, NY, January 17, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the dangerous side effects of vaginal mesh, supports the letters sent to vaginal mesh manufacturers by the U.S. Food and Drug Administration (FDA) requiring all 31 companies to conduct three-year studies of the products' safety and effectiveness.
The FDA's mandate was reported in a January 10 article that appeared on the Web site of Bloomberg Businessweek. The letters require the companies, which include C.R. Bard, Johnson & Johnson, and Boston Scientific to study rates of organ damage and other complications linked to vaginal mesh used in transvaginal procedures. Those procedures involve mesh products implanted through incisions in women's vaginas as treatment for a common condition known as pelvic organ prolapse. The companies have 30 days to respond.
Despite the FDA's mandate for more studies, vaginal mesh products are still widely used, with more than 300,000 devices implanted in women in 2010 alone. The devices received clearance for use under the FDA's 510(k) approval process, which states they are safe for use based on their similarity to other devices currently on the market. This approval process bypasses many of the stringent testing requirements necessary to bring new medical devices to market. To date, there have been 650 lawsuits filed by patients alleging that they have been significantly injured as a result of having a vaginal mesh product implanted in their bodies.
The Rottenstein Law Group hopes the publicity surrounding the letters sent by the FDA will serve as a warning to women who are considering having a vaginal mesh procedure, and that the number of women harmed by this device will eventually decline.
Anyone seeking more information about vaginal mesh can visit the Rottenstein Law Group's Vaginal Mesh Lawsuit Information Center. The site has vital information about the dangers of this medical device, along with easy-to-use social media features that allow for easy sharing on sites like Facebook and Twitter. Visitors are also encouraged to link to their own Web sites and blogs in order to spread the word about defective medical products and dangerous drugs.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

— WebWireID151605 —

WebWire® | More Feeds

]]> Biotechnology Class Actions / Lawsuits Health Care / Hospitals Legal Issues Medical / Pharmaceuticals WebWireID151605 Article